Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should patients with mitral stenosis and atrial fibrillation receive combined antithrombotic therapy?

Nature Clinical Practice Cardiovascular Medicine volume 3, pages 412–413 (2006)Cite this article

boxed-textPérez-Gómez et al. (2006) Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial. Eur Heart J 27: 960–967

Oral anticoagulants are the cornerstone of treatment in mitral stenosis and adjunctive antiplatelet therapy should be considered only in patients at risk of atherothrombotic cardiovascular events, but more investigation is needed

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pengo V et al. (2003) Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment. Thromb Haemost 89: 760–764

    Article  CAS  Google Scholar 

  2. Turpie AG et al. (1993) A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 329: 524–529

    Article  CAS  Google Scholar 

  3. van Es RF et al. (2002) Aspirin and Coumadin after acute coronary syndromes (the ASPECT-2study): a randomised controlled trial. Lancet 360: 109–113

    Article  CAS  Google Scholar 

  4. Hurlen M et al. (2002) Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347: 969–974

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Assistant Professor of Cardiology at the Department of Cardiologic, Thoracic and Vascular Sciences, University of Padua School of Medicine, Padua, Italy

    Vittorio Pengo

Authors
  1. Vittorio Pengo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vittorio Pengo.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pengo, V. Should patients with mitral stenosis and atrial fibrillation receive combined antithrombotic therapy?. Nat Rev Cardiol 3, 412–413 (2006). https://doi.org/10.1038/ncpcardio0612

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0612

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing